Phase II pilot study of induction erlotinib therapy in patients with resectable non-small cell lung cancer to select postoperative adjuvant therapy

被引：0
|
作者：
Lee, Dae Ho
Hong, Yong Sang
Kim, Tae Won
Jung, Kyung Hae
Kim, Sang -We
Suh, Cheolwon
Lee, Jung -Shin
Kim, Heung Tae
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2009年 / 8卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-09-C41
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C41
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Intensity of neoadjuvant therapy in resectable non-small cell lung cancer
    Green, MR
    Barkley, JE
    LUNG CANCER, 1997, 17 : S111 - S119
  • [32] Comprehensive study of neoadjuvant targeted therapy for resectable non-small cell lung cancer
    Bao, Yi
    Gu, Chang
    Xie, Huikang
    Zhao, Shengnan
    Xie, Dong
    Chen, Chang
    Jiang, Gening
    Dai, Chenyang
    Zhu, Yuming
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (06)
  • [33] A comparative study on erlotinib & gefitinib therapy in non-small cell lung carcinoma patients
    Thomas, Preenumol
    Vincent, Bini
    George, Christeena
    Joshua, Julie Mariam
    Pavithran, K.
    Vijayan, Meenu
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2019, 150 (01) : 67 - 72
  • [34] Adjuvant treatment for resectable non-small cell lung cancer
    Lim, Jeong Uk
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2023, 66 (03): : 173 - 179
  • [35] Postoperative radiation therapy in non-small cell lung cancer
    Emami, B
    Kaiser, L
    Simpson, J
    Shapiro, S
    Roper, C
    Lockett, MA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (05): : 441 - 448
  • [36] A phase III randomized trial of postoperative adjuvant therapy in Stage II or IIIA completely resected non-small cell lung cancer
    Yoon, S
    Choi, E
    Kim, S
    Suh, C
    Lee, J
    Shim, T
    Kim, W
    Kim, D
    Park, S
    Park, C
    LUNG CANCER, 2005, 49 : S288 - S288
  • [37] Postoperative Radiation Therapy for Non-Small Cell Lung Cancer
    Decker, Roy H.
    Wilson, Lynn D.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2008, 20 (03) : 184 - 187
  • [38] Aumolertinib as adjuvant therapy in postoperative EGFR-mutated non-small cell lung cancer
    Zhang, Q.
    He, C.
    He, T.
    Wang, Y.
    Lv, W.
    Hu, J.
    ANNALS OF ONCOLOGY, 2022, 33 : S73 - S73
  • [39] Induction erlotinib therapy in stage IIIA-N2 non-small cell lung cancer
    Zhong Wen-Zhao
    Yang Xue-Ning
    Guo Ai-Lin
    Chen Hua-Jun
    Su Jian
    Liao Ri-Qiang
    Zhou Qing
    Nie Qiang
    Xu Chong-Rui
    Yang Jin-Ji
    Wu Yi-Long
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S590 - S591
  • [40] Phase II pilot study of neoadjuvant docetaxel and cisplatin followed by adjuvant erlotinib in patients with stage I-III non-small cell lung cancer (NSCLC)
    Gold, K. A.
    Lee, J. J.
    Rice, D.
    Tse, W.
    Stewart, D.
    Wistuba, I.
    Herbst, R. S.
    Lippman, S. M.
    Hong, W. K.
    Kim, E. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345